CME Group Inc

CME has broken decisively below the 275 support cluster in a Stage 4 distribution environment, reinforced by a Support Failure pattern. The medium-term directional bias is bearish, and short-term conditions favor execution now as price fails at the 275–278 EMA resistance zone. While the long-term uptrend above the 200-day SMA remains intact, the immediate risk is further downside toward the 50-day EMA near 268–270. The recommended action is to sell now into the near-term resistance cluster, with a clear invalidation if price reclaims 275–278 and holds.

• ↑Q2 revenue of $1.7B (+1% YoY) on 29.8M contracts ADV
• ↑Market data revenue hit $238M (+20% YoY) and open interest +8%
• ↓Earnings yield at –1.6 and weak profitability score indicate margin strain